Envista (NYSE:NVST) Rating Lowered to Hold at Zacks Research

Envista (NYSE:NVST) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

Several other equities research analysts have also recently weighed in on the company. Stifel Nicolaus set a $31.00 target price on Envista in a research note on Friday, February 6th. Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. JPMorgan Chase & Co. boosted their target price on Envista from $22.00 to $26.00 and gave the stock a “neutral” rating in a research note on Friday, February 6th. Wells Fargo & Company boosted their target price on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Friday, February 6th. Finally, Leerink Partners set a $35.00 target price on Envista and gave the stock an “outperform” rating in a research note on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $27.75.

Envista Stock Up 8.9%

NYSE:NVST traded up $2.26 during mid-day trading on Monday, hitting $27.55. The stock had a trading volume of 323,621 shares, compared to its average volume of 2,830,182. The stock has a 50-day simple moving average of $26.72 and a two-hundred day simple moving average of $23.14. The company has a market capitalization of $4.51 billion, a PE ratio of 98.14, a PEG ratio of 1.76 and a beta of 0.98. Envista has a twelve month low of $14.22 and a twelve month high of $30.42. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The company’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, equities research analysts anticipate that Envista will post 1 EPS for the current year.

Insiders Place Their Bets

In other Envista news, SVP Mischa Reis sold 9,675 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the sale, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. The trade was a 23.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.66% of the company’s stock.

Institutional Investors Weigh In On Envista

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its stake in Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP lifted its stake in Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the last quarter. UMB Bank n.a. lifted its stake in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after buying an additional 636 shares during the last quarter. Finally, IFP Advisors Inc lifted its stake in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares during the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.